Skip to content
Dabur India logo

Dabur India

DABUR NSE
₹393.10 +2.45 (+0.63%)
Market Cap
₹69,734 Cr
P/E
34.42
View as Markdown
MCP
Close 20 Nov 2026 ₹393.10 1Y −119.30 −23.3%
Start ₹512.40

Key Fundamentals

MidcapPersonal ProductsFMCG

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
20.30%
Debt to Equity
0.13
EPS (TTM)
₹11.42
Book Value
₹64.78
Market Cap
₹69,734 Cr
P/E (TTM)
34.42
P/B
6.07
ROE
17.00%
Dividend Yield
0.90%
EBITDA
₹3,052 Cr
52W High
₹534.00
52W Low
₹354.30
Day Range
₹390.35 – ₹396.40
Volume
29,38,384

Peer Comparison

Fast Moving Consumer Goods › Personal Products › Personal Care

Dabur India peer comparison
919.5047.5794,0937.461.67%16.10%18.80%16,5371,978
Dabur India (this company)
393.1034.4269,7346.070.92%17.00%20.30%13,9242,001
365.65290.2049,16887.481.38%27.60%33.90%602169
1,760.0035.1547,86929.601.42%82.70%108.00%6,3911,362
7,090.5033.8023,10521.513.31%66.50%90.70%3,211683
7,020.0029.3422,78725.783.73%115.00%157.00%4,240776
422.2024.7618,4296.301.21%26.20%28.10%4,204747
Median 7 companies919.5034.4247,86921.511.42%27.60%33.90%4,240776

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

53 Average

Data confidence 100/100

Category scores

Quality
78
Strong
Returns, margins, earnings quality 22% weight
Valuation
36
Poor
Cheap vs sector & own history 24% weight
Growth
50
Average
Sales & profit trajectory 9% weight
Financial Health
85
Strong
Solvency, leverage, coverage 9% weight
Momentum
38
Weak
Trend strength, vol-adjusted 12% weight
Ownership
44
Weak
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has been maintaining a healthy dividend payout of 70.1%

Weaknesses

1
  • The company has delivered a poor sales growth of 6.65% over past five years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish577
OscillatorsNeutral171
Moving AveragesStrong Bullish406

Key readings

RSI (14)
58.68
Neutral
MACD (12,26,9)
2.41
Bullish
SMA (50)
380.00
Bullish
SMA (200)
427.41
Bearish

As of

Analyst Rating

Based on 37 analysts
BUY59%

22 of 37 analysts rate Buy, 12 Hold, 3 Sell.

As of

BUY
22
59%
HOLD
12
32%
SELL
3
8%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+5.42%
5Y+6.65%
3Y+4.59%
1Y+5.01%
TTM+8.94%

Net profit

Net profit growth by window
10Y+4.07%
5Y+1.97%
3Y+3.19%
1Y+7.41%
TTM+12.29%

Operating cash flow

Operating cash flow growth by window
10Y+8.07%
5Y+4.05%
3Y+20.12%
1Y+29.79%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−0.94 pp
5Y−2.37 pp
3Y−0.18 pp
1Y+0.13 pp
TTM−0.06 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹7,614 Cr
Mar 2018₹7,722 Cr
Mar 2019₹8,515 Cr
Mar 2020₹8,685 Cr
Mar 2021₹9,562 Cr
Mar 2022₹10,889 Cr
Mar 2023₹11,530 Cr
Mar 2024₹12,404 Cr
Mar 2025₹12,563 Cr
Mar 2026₹13,193 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1,280 Cr
Mar 2018₹1,358 Cr
Mar 2019₹1,446 Cr
Mar 2020₹1,448 Cr
Mar 2021₹1,695 Cr
Mar 2022₹1,742 Cr
Mar 2023₹1,701 Cr
Mar 2024₹1,811 Cr
Mar 2025₹1,740 Cr
Mar 2026₹1,869 Cr

Analyst Forecasts

Forecast For
Dec 26 consensus · EBITDA
₹792 Cr −1.5% vs Sep 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 17 Nov 2026
AI opinion · based on fundamentals
Risk medium

Dabur India Ltd trades at ₹384.3 as of 2026-11-17 with a market cap of ₹68,173 crore, sitting 28% below its 52-week high of ₹534. The company shows improving recent momentum with TTM sales growth of 9% and TTM profit growth of 13%, though longer-term compounded profit growth has been subdued at 2-4% over 3-5 year periods. The balance sheet remains conservatively managed with a debt-to-equity ratio of 0.11.

Bull Case 7
  • Near-zero leverage with a debt-to-equity ratio of just 0.11, providing significant financial flexibility and resilience against interest rate cycles
  • TTM profit growth has accelerated to 13%, a meaningful improvement over the 3-year compounded profit growth of 4% and 5-year compounded profit growth of 2%
  • Healthy dividend payout ratio of 70.1%, reflecting shareholder-friendly capital allocation with a current dividend yield of 0.92%
  • ROCE of 20.96% indicates efficient capital deployment and strong underlying business economics
  • TTM sales growth of 9% represents a clear acceleration compared to the 5-year compounded sales growth of 7% and 3-year compounded sales growth of 5%
  • Stock is trading at ₹384.3, only about 8% above its 52-week low of ₹354.3, which may reflect a degree of pessimism already priced in
  • 10-year ROE average of 21% demonstrates the company's ability to generate consistent returns on shareholder equity over long periods
Bear Case 8
  • Stock has delivered a 1-year return of -26% and a 5-year CAGR of -9%, indicating sustained value destruction for shareholders over multiple time horizons
  • PE ratio of 33.65 is elevated relative to the 5-year compounded profit growth of just 2%, implying the stock is priced for significantly higher growth than it has historically delivered
  • Poor sales growth of 6.65% over the past five years for an FMCG company suggests limited ability to drive volume or pricing gains
  • ROE has trended downward from a 10-year average of 21% to 17% in the last year, signalling deteriorating return efficiency
  • Price-to-book ratio of 5.93 is demanding given that the 3-year stock CAGR stands at -11%, meaning investors have paid a premium while returns have eroded
  • 10-year stock CAGR of just 3% has significantly underperformed broader market indices over the same period
  • 3-year compounded profit growth of 4% and 5-year compounded profit growth of 2% reflect structural earnings stagnation over medium-term horizons
  • The stock sits 28% below its 52-week high of ₹534, and the persistent downtrend from that level suggests the market has been re-rating the company lower

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

21h ago

TL;DR: Dabur delivered solid Q2FY27 growth with revenue up 11.6% and PAT up 11.7%, supported by premiumisation and distribution efficiency gains under Project Saksham. The SEBI administrative warning for delayed FDA disclosure is a governance blemish but the company says it had no financial impact. Leadership transition to a new CEO and strengthened audit oversight signal organisational reset. Near-term trajectory looks constructive if the Ignite strategy translates elevated A&P spending into sustained volume growth.

Headwinds 2
  • SEBI warning on delayed disclosure Nov 06

    SEBI issued an administrative warning to Dabur India for delaying disclosure of a US FDA warning letter received on July 24, 2026, citing violation of Regulation 30(6)(iii) of LODR Regulations. Repeated lapses could trigger enforcement action under the SEBI Act, 1992.

  • Subsidiary shut via liquidation Nov 11

    Dabur India closed its subsidiary Atlanta Body and Health Products through a voluntary liquidation process, indicating an orderly wind-down of that business line.

Positives 3
  • Strong Q2FY27 revenue and PAT Nov 10

    Q2FY27 consolidated revenue rose 11.6% YoY to ₹3,563 crore with PAT up 11.7%. Premium portfolio now contributes 20% of domestic business, targeting 23% by FY28.

  • Ignite strategy boosts A&P spend Nov 10

    New 'Ignite' strategy plans a 150-200 bps increase in advertising and promotion spend for core brands. Project Saksham reduced distributor count by 43% while doubling throughput.

  • EY appointed as joint auditor Nov 04

    Dabur's board appointed Ernst & Young LLP as Joint Internal Auditor alongside PwC Services LLP for the period ending March 31, 2028, strengthening internal audit oversight.

Neutral 4
  • New CEO and director appointments Nov 04

    Herjit Singh Bhalla appointed Whole-time Director and CEO-India effective Nov 14, 2026, replacing Mohit Malhotra. Postal ballot for his formal appointment and that of independent director Gopal Krishna Jain runs Nov 21 to Dec 20, 2026.

  • Interim dividend record date set Nov 03

    Dabur fixed November 10, 2026, as the record date for its FY27 interim dividend, subject to board approval on November 4.

  • KMP contact details updated Nov 13

    Dabur updated Key Managerial Personnel contact details effective Nov 14, 2026. Compliance Officer Ashok Kumar Jain serves until his superannuation on November 30, 2026.

Quarterly Results

₹ Cr
DABUR quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
3,204
3,255
2,815
3,349
3,029
3,355
2,830
3,405
3,191
3,559
3,038
3,764
3,563
Expenses
2,543
2,588
2,348
2,694
2,476
2,673
2,403
2,737
2,603
2,825
2,577
3,024
2,931
Operating Profit
661
667
466
655
553
682
427
667
588
734
461
741
632
OPM %
21%
20%
17%
20%
18%
20%
15%
20%
18%
21%
15%
20%
18%
Other Income
116
127
129
129
152
128
141
144
140
141
175
173
172
Interest
28
36
35
33
47
44
39
35
40
31
40
37
39.59
Depreciation
98
97
107
109
111
109
117
114
115
117
122
121
119
Exceptional Items
—
—
—
—
—
—
—
—
—
−15.05
—
—
—
PBT
651
662
453
643
546
657
412
663
573
711
475
756
646
Tax %
22%
23%
25%
23%
24%
22%
24%
23%
22%
22%
24%
22%
23%
Net Profit
507
506
341
494
418
516
313
508
445
554
362
586
499
EPS (₹)
2.91
2.90
1.97
2.82
2.40
2.95
1.81
2.90
2.55
3.16
2.08
3.33
2.85
YoY Sales growth
7
7
5
7
−5
3
1
2
5
6
7
11
12

Profit & Loss

₹ Cr
DABUR profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
7,795
7,780
7,614
7,722
8,515
8,685
9,562
10,889
11,530
12,404
12,563
13,193
13,924
Expenses
6,475
6,261
6,102
6,104
6,775
6,892
7,560
8,637
9,367
10,004
10,247
10,743
11,356
Operating Profit
1,320
1,518
1,512
1,617
1,740
1,792
2,002
2,252
2,162
2,400
2,316
2,450
2,568
OPM %
17%
20%
20%
21%
20%
21%
21%
21%
19%
19%
18%
19%
18%
Other Income
154
217
296
305
222
305
325
393
445
482
550
600
645
Interest
40
48
54
53
60
50
31
39
78
124
164
145
147
Depreciation
115
133
143
162
177
220
240
253
311
399
446
469
479
Exceptional Items
—
—
—
−14.54
—
−100
—
−85
—
—
—
−15.05
—
PBT
1,319
1,554
1,611
1,693
1,725
1,728
2,057
2,269
2,219
2,359
2,257
2,422
2,586
Tax %
19%
19%
21%
20%
16%
16%
18%
23%
23%
23%
23%
23%
—
Net Profit
1,068
1,254
1,280
1,358
1,446
1,448
1,695
1,742
1,701
1,811
1,740
1,869
2,000
EPS (₹)
6.07
7.11
7.25
7.69
8.17
8.18
9.58
9.84
9.64
10.40
9.97
10.68
11.42
Div. Payout %
33%
32%
31%
81%
34%
37%
50%
53%
54%
53%
80%
77%
—
Sales growth
10
0
−2
1
10
2
10
14
6
8
1
5
9

Balance Sheet

₹ Cr
DABUR balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
176
176
176
176
177
177
177
177
177
177
177
177
177
Reserves
3,178
3,995
4,671
5,530
5,455
6,429
7,487
8,205
8,796
9,689
10,623
11,242
11,315
Borrowings
734
805
975
938
699
522
509
1,030
1,174
1,365
950
1,287
1,445
Other Liabilities
2,019
1,956
1,910
2,058
2,106
2,209
2,661
2,872
3,505
3,885
4,479
4,773
4,932
Total Liabilities
6,106
6,932
7,732
8,702
8,437
9,337
10,833
12,284
13,652
15,116
16,230
17,480
17,869
Fixed Assets
1,877
1,667
1,958
2,028
1,969
2,253
2,243
2,308
3,579
3,815
3,990
3,938
3,797
CWIP
50
45
42
42
64
147
147
168
175
232
169
139
163
Investments
1,813
2,691
3,240
3,805
3,359
2,800
4,160
6,220
6,265
6,933
7,468
8,947
8,898
Other Assets
2,365
2,529
2,492
2,827
3,045
4,137
4,283
3,589
3,633
4,136
4,603
4,456
5,011
Total Assets
6,106
6,932
7,732
8,702
8,437
9,337
10,833
12,284
13,652
15,116
16,230
17,480
17,869

Cash Flow

₹ Cr
DABUR cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1,047
1,187
1,227
1,092
1,499
1,614
2,115
1,802
1,488
2,013
1,987
2,579
Investing
−876
−730
−807
−541
338
−517
−1,404
−1,273
−583
−971
−448
−1,279
Financing
−417
−374
−339
−577
−1,888
−1,043
−613
−490
−1,035
−1,161
−1,405
−1,236
Net Cash Flow
−245
82
81
−27
−51
54
97
38
−130
−119
133
64
Free Cash Flow
796
998
741
891
1,274
1,213
1,808
1,433
1,003
1,453
1,448
2,180
CFO/EBITDA
97
97
102
88
106
107
122
97
92
104
103
122

Ratios

DABUR financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
33
38
31
33
36
34
21
22
27
26
26
20
Inventory Days
136
150
153
169
154
164
178
169
158
149
175
166
Days Payable
153
182
181
190
172
176
197
178
171
186
215
212
Cash Conversion Cycle
16
6
3
13
17
22
3
12
14
−10
−14
−26
Working Capital Days
−17
0
−7
−1
−5
9
−9
−14
−13
−17
−13
−42
ROCE %
36%
35%
31%
28%
28%
28%
27%
27%
23%
22%
20%
20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Dabur India insights

74 extracted metrics across FY07–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 66.25%
  • DIIs 18.35%
  • FIIs 9.61%
  • Public 4.65%
  • Others 1.14%

No promoter shares pledged as of Sep 2026

Change since Jun 2026

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Dabur India

What does Dabur India Ltd do?
Dabur is India’s leading FMCG, Ayurvedic and natural health care company with wide network distribution across world.
Where is Dabur India Ltd (DABUR) listed?
Dabur India Ltd trades as DABUR on the NSE and under code 500096 on the BSE.
Which sector does Dabur India Ltd belong to?
Dabur India Ltd is classified under the Fast Moving Consumer Goods sector, in the Personal Products industry.
What is the market capitalisation of Dabur India Ltd?
Dabur India Ltd has a market capitalisation of ₹69,734 Cr as of 20 Nov 2026, which places it in the Midcap band.
What is the PE ratio of Dabur India Ltd?
Dabur India Ltd trades at a PE ratio of 34.42 as of 20 Nov 2026, on earnings per share of ₹11.42, against a book value of ₹64.78 per share.
What is the 52-week high and low of Dabur India Ltd?
Over the last 52 weeks Dabur India Ltd has traded between ₹354.3 and ₹534 as of 20 Nov 2026.
Does Dabur India Ltd pay dividends?
Dabur India Ltd has a dividend yield of 0.90%.
What is the Return on Equity (ROE) of Dabur India Ltd?
Dabur India Ltd reported a return on equity of 17.00%. Its debt-to-equity ratio is 0.13.

Company Information

Dabur is India’s leading FMCG, Ayurvedic and natural health care company with wide network distribution across world.

Website dabur.com
CEO Mr. Mohit Malhotra M.B.A.
Employees 5,341
Listed 28 Apr 1999
Face Value ₹1
Shares Outstanding 1,77,39,57,026

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DABUR.md for Dabur India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More